boostAGErx review
Ninety-five dollars is three months paid at once, divided by three. No invoice ever reads that figure.
The verdict
boostAGErx leads with from $95 monthly, which is what three months bought outright work out to per month. Anyone paying as they go is billed $225 per 28-day cycle, landing at $244 against the calendar.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $244/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Two injected products sold either as three months handed over at once or in 28-day cycles at a considerably higher rate.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages sell plans; nothing describes the clinical side.
Dividing a lump sum by three produces a number, not a price. Nobody is billed $95 in a month, and the term behind it sits in a footnote.
What happens when the dose goes up?
The seller writes that the real price varies by product and plan. That admits the figure moves and stops short of saying where.
What the price includes
Buying three months outright works out at $95 monthly on semaglutide and $145 on tirzepatide. A buy-now, pay-later program can carry that charge. Going cycle by cycle costs $225 and $265 every 28 days, landing thirteen times annually. Against the calendar that is $244 and $287. Roughly $1,800 a year separates the two routes on semaglutide.
What it claims, and what it cites
Compounded to order rather than manufactured. Nobody at the FDA inspects the finished vial before it ships.
Where it holds up, and where it does not
- Strength: Both routes appear on the page
- Strength: Buying outright genuinely saves a lot
- Strength: Each drug carries a figure
- Limitation: The lead figure is arithmetic, not a bill
- Limitation: 28-day cycles land thirteen times annually
- Limitation: Three months are handed over before dose one
- Limitation: Nothing addresses getting money back
What the evidence says about this kind of treatment
The assessment above is about boostAGErx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader sure of the drug who can hand over three months at once.
- Wrong for
- A reader who takes $95 for what a month costs.
The evidence behind what boostAGErx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How boostAGErx compares
| Seller | Who it suits | Go |
|---|---|---|
 Bodybuilding Health+ | A reader unwilling to prepay a year before seeing how the drug goes | See Bodybuilding Health+ → |
 bmiMD | Readers who want a microdose and understand that is what the low figure buys | See bmiMD → |
 Blue Haven RX | Readers who read the term definition rather than the word beside the price | See Blue Haven RX → |
More GLP-1 telehealth sellers reviews: Society of YouSomi HealthSomira HealthSouthern Vitality and Weight LossSpryStackMD
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does anyone pay $95 in a month?
- No. It is a three-month total divided by three.
- What does going cycle by cycle cost?
- $244 against the calendar on semaglutide, $287 on tirzepatide.
- Can money be recovered?
- The pages do not address it.
- Is boostAGErx expensive compared with other GLP-1 telehealth sellers?
- boostAGErx publishes a starting figure of $244/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts boostAGErx above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.